[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Nanchong Central Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":262},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,11,0,[8,41,61,82,107,127,154,173,199,219,240],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100640416","the-value-of-early-postoperative-colonoscopy-in-the-early-diagnosis-of-anastomotic-leakage-after-surgery-for-low-colorectal-cancer-100640416",false,"NCT07588386","The Value of Early Postoperative Colonoscopy in The Early Diagnosis of Anastomotic Leakage After Surgery for Low Colorectal Cancer","The Value of Early Postoperative Colonoscopy in The Early Diagnosis of Anastomotic Leakage After Surgery for Low Colorectal Cancer:A Randomized Controlled Trial","Inclusion Criteria:\n\n1. Age 18-80 years old.\n2. Pathologically diagnosed as colorectal adenocarcinoma.\n3. The distance between the lower edge of the tumor and the anal verge is ≤15cm.\n4. Accept laparoscopic or open radical resection and complete primary colorectal or colosal anastomosis.\n5. Voluntarily participate and sign the written informed consent.\n\nExclusion Criteria:\n\n1. Distant metastasis was confirmed by emergency operation, palliative operation or intraoperative metastasis (M1).\n2. Unsatisfactory anastomosis or poor blood circulation were found during the operation, and reinforcement suture or preventive colostomy were performed during the operation.\n3. There are serious contraindications for enteroscopy (such as acute myocardial infarction, severe cardiopulmonary insufficiency, blood coagulation dysfunction, etc.).\n4. Pregnant or lactating women.\n5. Previous history of colorectal surgery (except endoscopic polypectomy).\n6. Unable to understand or cooperate with the research process.","ALL","18 Years","80 Years",{"count":20,"type":21},140,"ESTIMATED","INTERVENTIONAL",[24],"NA","The goal of this clinical trial is to learn whether early postoperative colonoscopy is valuable in the early diagnosis of anastomotic leakage after surgery for low colorectal cancer.The main questions it aims to answer are:\n\n1. Will the median diagnosis time of AL in the intervention group (early colonoscopy group) be significantly shorter than that in the control group?\n2. Can targeted treatment (such as endoscopic vacuum therapy (EVT)) be initiated earlier in the early colonoscopy group, thereby reducing the incidence of AL and the rate of unplanned re-laparotomy?\n\nResearchers will compare the median diagnosis time of AL in the intervention group (early colonoscopy group) with the control group to observe whether early postoperative colonoscopy can detect anastomotic leakage earlier.\n\nParticipants will:\n\nExperimental group (early colonoscopy group):\n\n1. Colonoscopy will be performed on the 5th to 8th day after surgery (the surgeon will decide the specific date within this time window based on the patient's recovery).\n2. Carry out adequate intestinal preparation before the examination (the specific plan is formulated according to the hospital's routine, which may involve antegrade or retrograde enema, etc., and needs to be recorded and standardized).\n\nControl group (routine observation group):\n\n1. Receive standard postoperative management, including monitoring vital signs, abdominal signs, drainage fluid properties, etc.\n2. Only when clinical symptoms suspected of anastomotic leakage occur (such as persistent fever, worsening abdominal pain, turbid drainage fluid or stool samples), CT scan, gastrointestinal angiography or diagnostic colonoscopy should be performed according to clinical indications.",[27],"Anastomotic Leakage","RECRUITING","2026-06-20",{"date":31,"type":32},"2026-06-25","ACTUAL",{"date":34,"type":21},"2026-06-21",{"date":36,"type":21},"2027-06-30",{"name":38,"class":39},"Nanchong Central Hospital","OTHER_GOV",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":22,"phases":50,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":56,"startDateStruct":57,"completionDateStruct":58,"leadSponsor":60,"locationsCount":40},"100639650","oral-lactulose-for-gastrointestinal-recovery-after-complex-appendectomy-100639650","NCT07589465","Oral Lactulose for Gastrointestinal Recovery After Complex Appendectomy","Oral Lactulose for Postoperative Gastrointestinal Recovery After Complex Appendectomy: A Prospective Triple-Blind Placebo-Controlled Single-Center Randomized Trial","Inclusion Criteria:\n\n* 1.Age ≥18 years.2.Complicated appendicitis confirmed by SAS2.0 score, intraoperative findings, or pathology.3.Undergoing appendectomy (open or laparoscopic).4.Able to provide informed consent and comply with follow-up.\n\nExclusion Criteria:\n\n* 1.Preoperative intestinal obstruction, IBD, or intestinal tumor.2.Planned postoperative fasting \\>48 hours.3.Hypersensitivity to lactulose or placebo.4.Severe organ dysfunction (ASA ≥IV).5.Pregnancy or lactation.6.Cognitive or psychiatric disorder impairing follow-up.",{"count":49,"type":21},150,[24],"This is a prospective, triple-blind, placebo-controlled, single-center randomized clinical trial to evaluate the efficacy and safety of early oral lactulose for promoting postoperative gastrointestinal functional recovery in patients undergoing appendectomy for complicated appendicitis. Eligible patients aged ≥18 years with complicated appendicitis confirmed by preoperative SAS 2.0 score, intraoperative findings, or postoperative pathology will be randomly assigned 1:1 to receive oral lactulose or placebo on postoperative day 1 and day 2. The primary outcome is time to GI-2 (time from surgery to the later of first defecation or first tolerance of solid food). Secondary outcomes include time to first flatus, defecation rate within 72 hours, postoperative nausea and vomiting, length of hospital stay, medical costs, postoperative complications, and lactulose-related adverse events. A total of 150 patients will be enrolled. This study aims to provide high-level evidence for optimizing postoperative management in patients with complicated appendicitis.",[53,54,55],"Ileus Postoperative","Gastrointestinal Function","Complicated Appendicitis",{"date":31,"type":32},{"date":34,"type":21},{"date":59,"type":21},"2029-06-30",{"name":38,"class":39},{"id":62,"slug":63,"hasResults":11,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":4,"eligibilityCriteria":67,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":68,"targetDuration":4,"studyType":22,"phases":70,"briefSummary":71,"conditions":72,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":40},"100637570","treatment-of-post-stroke-central-pain-100637570","NCT07593313","Treatment of Post-Stroke Central Pain","Efficacy and Safety of Short-Term Spinal Cord Stimulation Combined With Pharmacotherapy for Central Post-Stroke Pain: A Single-Center, Randomized, Controlled Trial","Inclusion Criteria:\n\n* Diagnosis of central post-stroke pain (CPSP) according to the International Association for the Study of Pain (IASP) criteria\n* Clear history of stroke confirmed by cranial CT or MRI\n* Pain occurring after stroke and distributed in body parts corresponding to central nervous system injury\n* Pain with neuropathic characteristics (e.g., burning sensation, electric shock sensation, needle prick sensation)\n* Pain not explained by other causes\n* Age ≥ 18 years\n* Pain duration ≥ 3 months\n* Baseline pain Numerical Rating Scale (NRS) score ≥ 4 points\n* Complete clinical data with follow-up time ≥ 6 months\n\nExclusion Criteria:\n\n* History of chronic pain before stroke\n* Severe cognitive impairment that prevents cooperation with pain assessment (Mini-Mental State Examination, MMSE \\\u003C 15 points)\n* Contraindications to spinal cord stimulation (SCS), such as coagulation disorders, active infections, or mental diseases that prevent cooperation\n* Malignant tumors or other severe organic diseases with expected survival \\\u003C 1 year",{"count":69,"type":21},80,[24],"To evaluate the short-term analgesic efficacy of stSCS combined with pharmacotherapy compared with pharmacotherapy alone in patients with CPSP, measured by Numerical Rating Scale (NRS) score immediately after treatment.",[73],"Central Post-Stroke Pain","2026-05-13",{"date":76,"type":32},"2026-05-18",{"date":78,"type":32},"2024-01-01",{"date":80,"type":21},"2026-08-01",{"name":38,"class":39},{"id":83,"slug":84,"hasResults":11,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":4,"eligibilityCriteria":88,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":89,"enrollmentInfo":90,"targetDuration":4,"studyType":22,"phases":92,"briefSummary":93,"conditions":94,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":40},"100582883","chlorhexidine-gluconate-versus-saline-for-flushing-the-surgical-area-during-colorectal-cancer-surgery-100582883","NCT06869096","Chlorhexidine Gluconate Versus Saline for Flushing the Surgical Area During Colorectal Cancer Surgery","A Comparative Study of Chlorhexidine Versus Saline Irrigation of the Surgical Area During Colorectal Cancer Surgery: a Multicenter, Stratified Randomized Controlled Trial.","Inclusion Criteria:\n\n1. Patients aged 18-85 years,\n2. Patients with surgically resectable colorectal tumors confirmed by CT\u002FMRI before surgery\n3. All patients had a performance status score of 0 or 1 in the Eastern Tumor Cooperative group\n4. American Society of Anesthesiology grade I-III\n\nExclusion Criteria:\n\n1. The tumor may have distant metastasis\n2. History of previous abdominal surgery\n3. The patient has a history of other malignant tumors diagnosed in the past 5 years and has received radiotherapy and chemotherapy in the past\n4. There are obvious contraindications to surgery (obvious abnormal liver and kidney function, pregnancy)\n5. Participated in other clinical trials within the past 6 months","85 Years",{"count":91,"type":21},532,[24],"The aim of this study was to compare the effectiveness of chlorhexidine versus saline in flushing the surgical area during colorectal cancer surgery. The primary outcomes included surgical site infection, postoperative complication rates, et al.",[95,96,97,98],"Colorectal Cancer","Surgical Site Infection","Chlorhexidine","Complications","2026-03-29",{"date":101,"type":32},"2026-03-31",{"date":103,"type":32},"2024-07-02",{"date":105,"type":21},"2026-12-31",{"name":38,"class":39},{"id":108,"slug":109,"hasResults":11,"nctId":110,"briefTitle":111,"officialTitle":112,"acronym":4,"eligibilityCriteria":113,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":89,"enrollmentInfo":114,"targetDuration":4,"studyType":22,"phases":116,"briefSummary":117,"conditions":118,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":121,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":40},"100582617","efficacy-and-safety-of-colorectal-anastomotic-leak-testing-100582617","NCT06865638","Efficacy and Safety of Colorectal Anastomotic Leak Testing","A Comparative Study of Clinical Outcomes Between Leak Testing and No Leak Testing for Anastomosis in Colorectal Cancer Surgery: a Multicenter, Stratified Randomized Controlled Trial.","Inclusion Criteria:\n\n1. Patients diagnosed with colorectal cancer by pathology and scheduled for surgical treatment who meet the surgical indications.\n2. Aged between 18 and 85 years.\n3. American Society of Anesthesiologists (ASA) physical status classification is I - III.\n4. The patient or his\u002Fher legal representative can understand and sign the informed consent form and is willing to cooperate throughout the study process.\n\nExclusion Criteria:\n\n1. Patients with preoperatively diagnosed anastomotic leak or other severe abdominal infections.\n2. Patients with severe cardiovascular and cerebrovascular diseases (such as recent myocardial infarction, unstable angina pectoris, severe heart failure, acute cerebral infarction, etc.) who cannot tolerate surgery and related tests.\n3. Patients with severely impaired liver and kidney function (liver function Child - Pugh classification C or above, creatinine clearance rate \\\u003C 30 ml\u002Fmin).\n4. Patients with coagulation disorders (such as platelet count \\\u003C 50×10⁹\u002FL, international normalized ratio (INR) \\> 1.5, etc.) that cannot be corrected or are receiving anticoagulant therapy that cannot be adjusted.\n5. Patients with a history of abdominal radiotherapy or multiple abdominal surgeries and severe abdominal adhesions that may affect the operation and detection procedures.\n6. Patients with other malignant tumors who are receiving active anti-tumor treatment such as radiotherapy and chemotherapy.\n7. Patients with mental illness or cognitive impairment who cannot cooperate with the study process and follow-up.",{"count":115,"type":21},264,[24],"To evaluate the effectiveness of the gastroscopy, air, and methylene blue (GAM) leak testing in reducing the incidence of postoperative anastomotic complications, especially anastomotic leakage, in patients with colorectal cancer. The primary outcomes included is the incidence of anastomotic complications (mainly anastomotic leak) within 30 days after surgery",[95,119,120,98,27],"Leakage Testing","Colorectal Surgery",{"date":101,"type":32},{"date":123,"type":32},"2024-12-22",{"date":125,"type":21},"2029-04-01",{"name":38,"class":39},{"id":128,"slug":129,"hasResults":11,"nctId":130,"briefTitle":131,"officialTitle":132,"acronym":4,"eligibilityCriteria":133,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":89,"enrollmentInfo":134,"targetDuration":4,"studyType":22,"phases":136,"briefSummary":137,"conditions":138,"keywords":142,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":148,"startDateStruct":149,"completionDateStruct":151,"leadSponsor":153,"locationsCount":40},"100551814","stapler-reinforcement-patches-compared-to-standard-staplers-in-gastrojejunostomy-100551814","NCT06464978","Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy","The Impact of Stapler Reinforcement Patches Compared to Standard Staplers on Postoperative Complications in Gastrojejunostomy: A Multicenter Randomized Controlled Trial","Inclusion Criteria:\n\n* Age between 18 and 85 years.\n* Pathologically diagnosed with gastric cancer and suitable for distal gastrectomy or subtotal gastrectomy.\n* ECOG performance status of 0 or 1.\n* ASA (American Society of Anesthesiologists) classification of I-III.\n* Voluntary signed informed consent from the participant or their legal representative.\n\nExclusion Criteria:\n\n* Evidence of potential distant metastasis found preoperatively.\n* History of other malignancies diagnosed within the past 5 years, or any malignancy treated with chemotherapy or radiotherapy.\n* Significant contraindications for surgery (e.g., severe liver or kidney dysfunction).\n* Participation in any other clinical trial within the last 6 months.\n* Participants or their legal representatives unwilling to sign the informed consent or comply with the study protocol.",{"count":135,"type":21},382,[24],"This is a multi-center, prospective, randomized controlled study aimed at compareing the impact of stapler reinforcement patches versus standard staplers on postoperative complications in gastrojejunostomy.",[139,140,27,141],"Gastric Cancer","Gastrostomy","Postoperative Complications",[143,144,145,146,147],"Stapler Reinforcement Patch","Gastrojejunostomy","Randomized Controlled Trial","Surgical Outcomes","Complication Prevention",{"date":101,"type":32},{"date":150,"type":32},"2024-05-30",{"date":152,"type":21},"2028-12-31",{"name":38,"class":39},{"id":155,"slug":156,"hasResults":11,"nctId":157,"briefTitle":158,"officialTitle":158,"acronym":4,"eligibilityCriteria":159,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":89,"enrollmentInfo":160,"targetDuration":4,"studyType":22,"phases":162,"briefSummary":163,"conditions":164,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":167,"startDateStruct":168,"completionDateStruct":170,"leadSponsor":172,"locationsCount":40},"100478806","proximal-gastrectomy-anterior-anastomosis-with-pyloroplasty-versus-esophagogastric-anastomosis-for-gastric-cancer-100478806","NCT05514769","Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer","Inclusion Criteria:\n\n1. Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages.\n2. Eastern Cooperative Oncology Group performance status of 0 or 1.\n3. Adequate organ function.\n\nExclusion Criteria:\n\n1. Patients had distant metastasis.\n2. oesophageal invasion of more than 3 cm.\n3. Borrmann type 4 or large (more than 8 cm) type 3 carcinoma.\n4. Previous chemotherapy or radiation therapy for any other malignancies.",{"count":161,"type":21},60,[24],"This research is designed to compare proximal gastrectomy anterior anastomosis with pyloroplasty with esophagogastric anastomosis for gastric cancer. Gastroesophageal reflux disease, postoperative quality of life, short term outcomes, and long term outcomes will be compared.",[165,139,166],"Proximal Gastric Adenocarcinoma","Gastroesophageal Reflux Disease",{"date":101,"type":32},{"date":169,"type":32},"2021-01-01",{"date":171,"type":21},"2027-12-31",{"name":38,"class":39},{"id":174,"slug":175,"hasResults":11,"nctId":176,"briefTitle":177,"officialTitle":178,"acronym":4,"eligibilityCriteria":159,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":179,"enrollmentInfo":180,"targetDuration":4,"studyType":22,"phases":182,"briefSummary":183,"conditions":184,"keywords":187,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":193,"startDateStruct":195,"completionDateStruct":197,"leadSponsor":198,"locationsCount":40},"100466924","linear-stapler-versus-circular-stapler-in-esophagojejunostomy-100466924","NCT05360069","Linear Stapler Versus Circular Stapler in Esophagojejunostomy","Linear Stapler Versus Circular Stapler in Esophagojejunostomy for Patients With Gastric Cancer Underwent Laparoscopic Total Gastrectomy","90 Years",{"count":181,"type":21},100,[24],"With the development of stapler devices, various methods of esophagojejunostomy after laparoscopic total gastrectomy were evoluated. Which stapler is more advantageous has not been determined. At present, the most commonly used is linear stapler or Circular stapler in esophagojejunostomy. However, there is still a lack of reliable evidence for the selection of the two staplers. The purpose of this study is to explore the advantages of linear staper versus circular stapler in esophagojejunostomy for patients with gastric cancer who underwent total gastrectomy.",[141,185,186],"Operative Time","Hospital Costs",[188,189,190,191,192],"laparoscopy","total gastrectomy","esophagojejunostomy","linear stapler","circular stapler",{"date":194,"type":32},"2026-04-02",{"date":196,"type":32},"2020-01-01",{"date":152,"type":21},{"name":38,"class":39},{"id":200,"slug":201,"hasResults":11,"nctId":202,"briefTitle":203,"officialTitle":204,"acronym":4,"eligibilityCriteria":205,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":89,"enrollmentInfo":206,"targetDuration":4,"studyType":22,"phases":208,"briefSummary":209,"conditions":210,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":212,"lastUpdatePostDateStruct":213,"startDateStruct":214,"completionDateStruct":216,"leadSponsor":218,"locationsCount":40},"100608994","pre-emptive-endoscopic-vacuum-therapy-reduces-the-incidence-of-anastomotic-leakage-after-colorectal-cancer-surgery-100608994","NCT07208786","Pre-emptive Endoscopic Vacuum Therapy Reduces the Incidence of Anastomotic Leakage After Colorectal Cancer Surgery","Randomized Clinical Trial on Pre-emptive Endoscopic Vacuum Therapy Versus Conventional Management for the Prevention of Anastomotic Leakage After Colorectal Cancer Surgery","Inclusion Criteria:\n\n1. Pathologically diagnosed with colorectal cancer, planned for radical surgery (right hemicolectomy, left hemicolectomy, or anterior resection of the rectum, etc.).\n2. Age 18-85 years, American Society of Anesthesiologists (ASA) classification I-III.\n3. Anastomosis to be performed in a single stage (meeting anastomotic criteria).\n4. Patient or legal guardian is able to understand and sign the informed consent form and comply with follow-up.\n\nExclusion Criteria:\n\n1. Preexisting anastomotic leakage or severe intra-abdominal infection before surgery.\n2. Complicated by severe cardiovascular or cerebrovascular diseases (e.g., acute myocardial infarction, acute phase of cerebral infarction).\n3. Severe liver or kidney dysfunction (liver function Child-Pugh class C, creatinine clearance \\\u003C30 ml\u002Fmin).\n4. Coagulation disorders (platelets \\\u003C50×10⁹\u002FL, INR \\>1.5) or receiving anticoagulant therapy that cannot be adjusted.\n5. History of abdominal radiotherapy or multiple abdominal surgeries leading to severe intra-abdominal adhesions.\n6. Complicated by other malignant tumors and currently undergoing radiotherapy or chemotherapy.\n7. Psychiatric illness or cognitive impairment preventing compliance with the study.",{"count":207,"type":21},110,[24],"Evaluate the safety and efficacy of postoperative Pre-emptive EVT (PEVT) in reducing the incidence of anastomotic leaks within 30 days after surgery in patients with colorectal cancer. Compare the differences between the PEVT group and the control group in terms of operation time, length of hospital stay, and total medical costs. Analyze the incidence of other postoperative complications in the two groups, such as wound infection, abdominal abscess, and intestinal obstruction. Assess the impact of PEVT on postoperative recovery indicators, including time to first flatus, time to first defecation, and time to ambulation. Observe the occurrence of PEVT-related adverse events, such as device displacement, bleeding, and infection.",[95,120,98,27,211],"Endoscopic Vacuum Therapy","2026-03-28",{"date":194,"type":32},{"date":215,"type":32},"2025-09-22",{"date":217,"type":21},"2026-12-30",{"name":38,"class":39},{"id":220,"slug":221,"hasResults":11,"nctId":222,"briefTitle":223,"officialTitle":224,"acronym":4,"eligibilityCriteria":159,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":179,"enrollmentInfo":225,"targetDuration":4,"studyType":22,"phases":227,"briefSummary":228,"conditions":229,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":232,"lastUpdatePostDateStruct":233,"startDateStruct":235,"completionDateStruct":237,"leadSponsor":239,"locationsCount":40},"100385189","reduced-port-laparoscopic-gastrectomy-for-gastric-cancer-100385189","NCT04295473","Reduced Port Laparoscopic Gastrectomy for Gastric Cancer","Comparison the Short and Long-term Outcome of Patients With Gastric Cancer Who Underwent Reduced Port Laparoscopic Gastrectomy With Patients Underwent Traditional Laparoscopic Gastrectomy",{"count":226,"type":21},160,[24],"Reduced port laparoscopic gastrectomy has been adopted in clinical. The safety and outcome of reduced port laparoscopic gastrectomy has not been systematically evaluated. The investigators sought to compare the short and long-term outcome of patients with gastric cancer who underwent reduced port gastrectomy with patients underwent traditional laparoscopic gastrectomy",[230,231],"Laparoscopic","Gastrectomy","2025-05-16",{"date":234,"type":32},"2025-05-21",{"date":236,"type":32},"2020-03-02",{"date":238,"type":21},"2027-03-01",{"name":38,"class":39},{"id":241,"slug":242,"hasResults":11,"nctId":243,"briefTitle":244,"officialTitle":245,"acronym":4,"eligibilityCriteria":246,"healthyVolunteers":11,"sex":247,"minAge":17,"maxAge":4,"enrollmentInfo":248,"targetDuration":4,"studyType":22,"phases":250,"briefSummary":251,"conditions":252,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":255,"lastUpdatePostDateStruct":256,"startDateStruct":258,"completionDateStruct":260,"leadSponsor":261,"locationsCount":40},"100584165","uterine-round-ligament-preservation-vs-resection-in-laparoscopic-inguinal-hernia-repair-in-womena-multicenterstratified-randomized-controlled-trial-100584165","NCT06885788","Uterine Round Ligament Preservation Vs Resection in Laparoscopic Inguinal Hernia Repair in Women：A Multicenter,Stratified Randomized Controlled Trial","Comparative Study on the Effect of Uterine Round Ligament Preservation Vs Resection in Laparoscopic Inguinal Hernia Repair in Women： a Multicenter,Stratified Randomized Controlled Trial","Inclusion Criteria:\n\n* ►Age : Female patients over 18 years of age without a childbearing requirement\n\n  * Diagnosis and basis : Female patients diagnosed with Unilateral inguinal hernia.\n  * agreed to participate in this study and signed the informed consent form.\n\nExclusion Criteria:\n\n* ►Combined with severe heart, liver, kidney and other diseases.\n\n  * pregnant or lactating women.\n  * those with surgical contraindications.","FEMALE",{"count":249,"type":21},466,[24],"This study aims to compare the clinical effects of uterine round ligament preservation versus resection in laparoscopic inguinal hernia repair in women.The primary outcomes included Time required for patient surgery.The secondary outcomes included Inguinal hernia recurrence,quality of life assessment,Indicators of postoperative recovery,, et al.",[253,254,145],"Inguinal Hernia","Laparoscopic Surgery","2025-03-20",{"date":257,"type":32},"2025-03-25",{"date":259,"type":32},"2024-09-20",{"date":238,"type":21},{"name":38,"class":39},""]